N-PORT filing recap · September 2025
What did Hillman Value Fund buy in September 2025?
Reported stock-position changes between this filing and the previous one. These are Hillman Value Fund's own holdings, not the firm's.
Stock value
$101.01M
Positions
39
Estimated turnover
35.8%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
Period in review
Hillman Value Fund opened new positions in UnitedHealth Group, West Pharmaceutical Services, UPS, Fiserv, and Akamai Technologies, while exiting AT&T, Advanced Micro Devices, Alphabet, The Options Clearing Corporation, West Pharmaceutical Services, and Microchip Technology. The fund trimmed GSK, Pfizer, Estee Lauder, DuPont, ASML, Kraft Heinz, Hershey, CVS Health, Biogen, Taiwan Semiconductor, Boeing, Microsoft, T. Rowe Price, Nucor, Nike, and US Bancorp, and substantially reduced Warner Bros. Discovery. It also added to Baxter International.